- Sabic Agri-Nutrients reported revenue of 3.07 billion riyals for the first quarter, marking a 22% year-over-year increase, surpassing the estimated 2.91 billion riyals.
- The company’s earnings before interest, taxes, depreciation, and amortization (Ebitda) reached 1.08 billion riyals, reflecting a 12% rise from the previous year.
- Ebitda margin decreased slightly to 35% from 38% compared to the same period last year.
- Free cash flow was recorded at 643 million riyals, experiencing a 41% decline year-over-year.
- From the analysts’ recommendations, there are 5 buy ratings, 7 hold ratings, and no sell ratings for Sabic Agri-Nutrients.
A look at Saudi Arabian Fertilizer Co Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 5 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
According to Smartkarma Smart Scores, Saudi Arabian Fertilizer Co shows a promising long-term outlook with high scores in Dividend and Resilience, indicating strong performance in these areas. The company manufactures agricultural supplies including fertilizers like ammonia and urea. With a top score of 5 in Dividend, investors can expect stable and attractive returns on their investment over time. Additionally, a score of 4 in Value suggests the company is currently trading at an attractive price relative to its intrinsic value.
While the Growth and Momentum scores are not as high, the overall outlook for Saudi Arabian Fertilizer Co remains positive due to its solid fundamentals and strong dividend track record. This indicates that despite moderate growth and momentum, the company’s resilience and dividends are key strengths that can appeal to long-term investors seeking stability and income generation.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
